Teva Pharmaceutical Industries TEVA
NYSE TEVA
$37.19 -0.28 (-0.76%)
At close: Aug 20, 2026 · 7:11 PM UTC

Teva Pharmaceutical Industries (TEVA) Gross Profit (QoQ) (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) Gross Profit (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.89 Bn 42.93 Bn -
2 Teva Pharmaceutical Industries 43.30 Bn 39.65 Bn 2.15 Bn
3 Zoetis 31.45 Bn 29.77 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.18%
Mar 31, 2026 -25.75%
Dec 31, 2025 15.28%
Sep 30, 2025 9.61%
Jun 30, 2025 11.99%
Mar 31, 2025 -11.50%
Dec 31, 2024 -1.26%
Sep 30, 2024 6.13%
Jun 30, 2024 14.29%
Mar 31, 2024 -26.70%
Dec 31, 2023 30.52%
Sep 30, 2023 3.06%
Jun 30, 2023 13.53%
Mar 31, 2023 -10.62%
Dec 31, 2022 6.05%
Sep 30, 2022 -6.97%
Jun 30, 2022 3.10%
Mar 31, 2022 -15.12%
Dec 31, 2021 14.27%
Sep 30, 2021 -4.22%